Trends of the incidence rate of Hepatitis C in Changsha, China, 2005 to 2023 and Its Prediction to 2025.

IF 1.4 4区 医学 Q4 INFECTIOUS DISEASES
Shuilian Chen, Ping Zeng, Kewei Yang, Xixing Zhang, Xuewen Yang, Yinzhu Zhou
{"title":"Trends of the incidence rate of Hepatitis C in Changsha, China, 2005 to 2023 and Its Prediction to 2025.","authors":"Shuilian Chen, Ping Zeng, Kewei Yang, Xixing Zhang, Xuewen Yang, Yinzhu Zhou","doi":"10.3855/jidc.19790","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Hepatitis C is a globally distributed hepatic disease with a high chronicity rate, posing significant global public health concerns. This research aimed to predict the incidence trend of hepatitis C to guide disease prevention and control.</p><p><strong>Method: </strong>The quarterly incidence rates of hepatitis C in Changsha from the first quarter of 2005 to the third quarter of 2023 were collected. Curve-fitting method, grey model (GM (1,1)), Autoregressive Integrated Moving Average (ARIMA) model, and Back Propagation Neural Network (BPNN) model, were applied to simulate the incidence trend of hepatitis C.</p><p><strong>Results: </strong>The annual average reported incidence rate in Changsha was 12.518 per 100,000. The incidence rate of hepatitis C showed an upward trend from 1.102 per 100,000 in 2005 to 17.172 per 100,000 in 2013 and remained at a high level from 2014 to 2019. It has been steadily declining since 2020. The BPNN model exhibited the best forecasting performance (MAE = 0.394, MRE = 0.203). The prediction results from the BPNN model estimated the incidence rate of hepatitis C to be 9.991 per 100,000 in 2024 and 11.920 per 100,000 in 2025.</p><p><strong>Conclusions: </strong>The incidence of hepatitis C in the next two years is projected to be slightly higher than that during the COVID-19 epidemic. It is imperative to strengthen various measures to achieve the goal of hepatitis C elimination in China.</p>","PeriodicalId":49160,"journal":{"name":"Journal of Infection in Developing Countries","volume":"19 1","pages":"140-145"},"PeriodicalIF":1.4000,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection in Developing Countries","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3855/jidc.19790","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Hepatitis C is a globally distributed hepatic disease with a high chronicity rate, posing significant global public health concerns. This research aimed to predict the incidence trend of hepatitis C to guide disease prevention and control.

Method: The quarterly incidence rates of hepatitis C in Changsha from the first quarter of 2005 to the third quarter of 2023 were collected. Curve-fitting method, grey model (GM (1,1)), Autoregressive Integrated Moving Average (ARIMA) model, and Back Propagation Neural Network (BPNN) model, were applied to simulate the incidence trend of hepatitis C.

Results: The annual average reported incidence rate in Changsha was 12.518 per 100,000. The incidence rate of hepatitis C showed an upward trend from 1.102 per 100,000 in 2005 to 17.172 per 100,000 in 2013 and remained at a high level from 2014 to 2019. It has been steadily declining since 2020. The BPNN model exhibited the best forecasting performance (MAE = 0.394, MRE = 0.203). The prediction results from the BPNN model estimated the incidence rate of hepatitis C to be 9.991 per 100,000 in 2024 and 11.920 per 100,000 in 2025.

Conclusions: The incidence of hepatitis C in the next two years is projected to be slightly higher than that during the COVID-19 epidemic. It is imperative to strengthen various measures to achieve the goal of hepatitis C elimination in China.

求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.70
自引率
5.30%
发文量
239
审稿时长
4-8 weeks
期刊介绍: The Journal of Infection in Developing Countries (JIDC) is an international journal, intended for the publication of scientific articles from Developing Countries by scientists from Developing Countries. JIDC is an independent, on-line publication with an international editorial board. JIDC is open access with no cost to view or download articles and reasonable cost for publication of research artcles, making JIDC easily availiable to scientists from resource restricted regions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信